Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Praeruptorin A: A Translational Map for Mechanism
2026-09-04
Praeruptorin A is an angular pyranocoumarin compound with a distinctive opportunity for mechanism-led translational research. By linking DMT1 and ferroptosis, inflammatory signaling and epithelial barrier repair, and ERK/MMP1-driven cancer invasion, researchers can use one scaffold to test disease-specific hypotheses while maintaining rigorous controls for exposure, causality, and model maturity.
-
Ibuprofen: From COX Biology to Translational Strategy
2026-09-03
Ibuprofen is more than a familiar non-steroidal anti-inflammatory drug: its COX biology, context-dependent anti-proliferative effects, and formulation considerations make it a useful translational research tool. This article connects colon cancer research, assay design, and drug–protein recognition to help researchers interpret results with greater mechanistic discipline.
-
Doxycycline Workflows for MMP2 Cancer Research
2026-09-02
Use Doxycycline as a controlled metalloproteinase-inhibition tool, antiproliferative comparator, and antimicrobial agent for research. This workflow guide shows how to separate matrix effects from cytotoxicity and how to translate MMP2-responsive delivery concepts into reproducible assays.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-02
Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 is a research reagent for detecting HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It should be used for controlled assay development and chromatin protein detection only, not for diagnostic, therapeutic, or medical applications.
-
Estradiol Benzoate: ERα Research Workflows
2026-09-01
Estradiol Benzoate provides a practical, high-affinity starting point for receptor binding, pathway activation, and species-aware estrogen studies. This guide combines solvent and assay optimization with a structure-based screening framework to improve reproducibility without overinterpreting computational or cellular readouts.
-
Praeruptorin A Applied Research Workflows
2026-09-01
Build practical Praeruptorin A workflows for ferroptosis, inflammation, intestinal-barrier, cardiomyopathy, and hepatocellular-carcinoma studies. The article emphasizes dose selection, orthogonal readouts, pathway validation, and troubleshooting rather than relying on a single biomarker.
-
EDC.HCl Coupling Workflow Guide
2026-08-31
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis and bioconjugation workflows. It is intended for controlled in vitro laboratory use; the dossier reports no in vivo or clinical data, and long-term storage of solutions is not recommended.
-
MG-132 Workflows for Proteasome Stress Assays
2026-08-31
MG-132 (Z-LLL-al) connects proteasome inhibition with practical apoptosis, cell-cycle, oxidative-stress, and protein-turnover readouts. This guide emphasizes dose mapping, imaging-compatible workflows, and troubleshooting that separates proteasome-specific biology from secondary toxicity.
-
(R,S)-Anatabine Workflows for Alzheimer’s Research
2026-08-30
(R,S)-Anatabine provides a practical way to connect amyloid precursor protein processing with neuroinflammatory signaling in translational Alzheimer’s studies. This guide covers cell-based screening, soluble Aβ peptide reduction workflows, assay controls, and troubleshooting for more reproducible Anatabine experiments.
-
RG108 Pharmacokinetics in Rats: Study Insights
2026-08-29
The reference study established an in vivo pharmacokinetic profile for RG108, a non-nucleosidic DNA methyltransferase inhibitor, after subcutaneous administration in rats. Its findings show measurable plasma and tissue exposure near reported inhibitory concentrations, supporting RG108 as a research tool for DNMT inhibition while leaving pharmacodynamic efficacy and long-term safety to be tested.
-
Y5: A Dimer-Interface AR Antagonist
2026-08-28
This 2025 Journal of Medicinal Chemistry study identifies benzo[b]oxepine derivatives that inhibit androgen receptor signaling through a non-canonical dimer interface pocket rather than the mutation-prone ligand-binding pocket. Optimization produced Y5, which combines potent antagonism, activity against resistant AR variants, AR degradation, and oral efficacy in an LNCaP xenograft model.
-
ECL Western Blotting Substrate: Workflow Guide
2026-08-28
ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection by chemiluminescence on immunoblots. It is intended for HRP-linked Western blot assays using X-ray film or CCD imaging, not for fluorescent or radioisotopic detection workflows.
-
Praeruptorin A: Assay Workflows and Applications
2026-08-27
Praeruptorin A converts an iron-centered screening concept into practical workflows for ferroptosis, doxorubicin cardiotoxicity, inflammation, and invasion studies. This guide emphasizes dose planning, orthogonal readouts, formulation control, and model-specific troubleshooting rather than relying on viability data alone.
-
HCMV UL38, IRS1, and AKT Signal Dampening
2026-08-27
The reference study identifies HCMV UL38 as a viral driver of mTORC1-dependent IRS1 destabilization, explaining how infected cells become less responsive to serum-mediated AKT activation. Its combination of fractionation, live-cell imaging, viral genetics, ectopic expression, and rapamycin rescue provides a useful framework for distinguishing impaired AKT membrane recruitment from simple changes in total kinase abundance.
-
Optimized hiPSC Platelet Differentiation: Study Insights
2026-08-26
A 2026 study in Stem Cell Reviews and Reports introduces an optimized differentiation scheme for generating functional platelets from human induced pluripotent stem cells. By increasing embryoid body input, refining serum-free medium with human platelet lysate, replacing selected cytokines with small molecules, and improving megakaryocyte maturation, the workflow shortened production, increased yield, and reduced estimated cost.